Metolazone (CAS 17560-51-9) – Diuretic API

Metolazone (CAS 17560-51-9) is a high-purity thiazide-like diuretic API with potent natriuretic and diuretic effects. Its core mechanism targets the distal convoluted tubule of the nephron, inhibiting sodium and chloride reabsorption to increase urinary excretion of water, sodium, and potassium. Unlike traditional thiazides, it retains efficacy even in patients with impaired renal function, delivering consistent performance for fluid retention management. Produced under GMP-compliant processes, it ensures ultra-low impurity levels, stable bioactivity, and compliance with international cardiovascular pharmaceutical standards.

This premium API is a key raw material for pharmaceutical manufacturers developing treatments for edema and hypertension. It is widely applied in formulating medications for congestive heart failure, renal edema, hepatic cirrhosis-related fluid retention, and refractory hypertension, often combined with other antihypertensives to enhance efficacy. With proven clinical safety and long-lasting action, it addresses the critical demand for reliable diuretic therapies in cardiovascular and nephrology care. For R&D teams and production enterprises, it provides a trusted solution to advance fluid balance and blood pressure management drug development.